Successful unmanipulated peripheral blood progenitor cell transplantation from an HLA haploidentical 2-locus-mismatched mother in a thalassemic patient with primary graft failure after transplantation of bone marrow and cord blood from unrelated donors

Pediatric Transplantation

Volumn 12, Issue 2, 2008, Pages 232-234

  Jaing, Tang Her ^a,b   Sun, Chien Feng ^c   Lee, Wen I ^a   Wen, Yu Chuan ^c   Yang, Chao Ping ^b   Hung, Iou Jih ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

thalassemia major; Haploidentical 2 loci mismatched mother; Retransplant

Indexed keywords

ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CASE REPORT; CHIMERA; CORD BLOOD STEM CELL TRANSPLANTATION; FETOPLACENTAL UNIT; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HAPLOIDY; HLA MATCHING; HUMAN; MALE; MYELOABLATIVE CONDITIONING; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; TREATMENT OUTCOME;

BETA-THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; CHIMERISM; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HLA ANTIGENS; HUMANS; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TISSUE DONORS;

EID: 40149085423     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00844.x     Document Type: Article

References (14)

1. Sadelain M, Boulad F, Galanello R, et al. Therapeutic options for patients with severe β-thalassemia: The need for globin gene therapy. Hum Gene Ther 2007 : 18 : 1 9.
2. Faraci M, Micalizzi C, Lanino E, et al. Three consecutive related bone marrow transplants for juvenile myelomonocytic leukaemia. Pediatr Transplant 2005 : 9 : 797 800.
3. Gaziev D, Galimberti M, Lucarelli G, et al. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants. Bone Marrow Transplant 2000 : 25 : 815 821.
4. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med 2005 : 353 : 1135 1146.
5. Cighetti G, Duca L, Bortone L, et al. Oxidative status and malondialdehyde in beta-thalassaemia patients. Eur J Clin Invest 2002 : 32 (Suppl. 1 55 60.
6. Ichinohe T, Maruya E, Saji H. Long-term feto-maternal microchimerism: Nature's hidden clue for alternative donor hematopoietic cell transplantation? Int J Hematol 2002 : 76 : 229 237.
7. Van Rood JJ, Loberiza FR, Zang MJ, et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 2002 : 99 : 1572 1577.
8. Tamaki S, Ichinohe T, Matsuo K, et al. Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts. Bone Marrow Transplant 2001 : 28 : 375 380.
9. Tsutsumi Y, Tanaka J, Miura T, et al. Successful non-T-cell-depleted nonmyeloablative hematopoietic stem cell transplantation (NST) from an HLA-haptoidentical 2-loci-mismatched sibling in a heavily transfused patient with severe aplastic anemia based on the fetomaternal microchimerism. Bone Marrow Transplant 2004 : 34 : 267 269.
10. Muller SM, Ege M, Pottharst A, Schulz AS, Schwarz K, Friedrich W. Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: A study of 121 patients. Blood 2001 : 98 : 1847 1851.
11. Giralt S, Estey E, Albitar M, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997 : 89 : 4531 4536.
12. Mcsweeney PA, Wagner JL, Maloney DG, et al. Outpatient PBSC allografts using immunosuppression with low-dose TBI before, and cyclosporine and mycophenolate mofetil after transplant. Blood 1998 : 92 : 519a (abstract).
13. Fisher VL, Barnes YJ, Nuss SL. Pretransplant conditioning in adults and children: Dose assurance with intravenous busulfan. Oncol Nurs Forum 2006 : 33 : E36 E43.
14. Nguyen L, Leger F, Lennon S, Puozzo C. Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: A population pharmacokinetic study. Cancer Chemother Pharmacol 2006 : 57 : 191 198.